Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00394329 · ClinicalTrials.gov registry record · Phase 3
(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 288
- Enrollment target
NCT00394329 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 288 participants.
The verdict
NCT00394329, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 288 participants
- Enrollment target
Study Summary
Asthma is a common, serious illness among children in the United States. It can be effectively controlled through the use of preventative medications and "rescue" medications, which are used to control symptoms. This study will evaluate the impact and severity of asthma exacerbations that occur in children with mild persistent asthma who are receiving various combinations of medications for daily and rescue use.
Interventions
- DRUG Albuterol sulfate
- DRUG Beclomethasone dipropionate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2006-11 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00394329
The ClinicalTrials.gov registry entry for NCT00394329 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Albuterol sulfate is the first listed.
NCT00394329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00394329 about?
NCT00394329 is a clinical study titled "(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)". Asthma is a common, serious illness among children in the United States. It can be effectively controlled through the use of preventative medications and "rescue" medications, which are used to control symptoms. This study will evaluate the impact and severity of asthma exacerbations that occur in c...
What is the current status of trial NCT00394329?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 288 participants. The study started on 2006-11. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00394329?
The interventions under investigation include: Albuterol sulfate (DRUG), Beclomethasone dipropionate (DRUG).
Who is sponsoring clinical trial NCT00394329?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.